Search research articles
Contact Us
Filters
Showing results (161-170 of 219) with videos related to
Page
of 22
Sort By:
Experimental Cell Research
|
May 1, 1983
The effect of the dimeric and multimeric forms of fibronectin on the adhesion and growth of primary glomerular cells
T D Oberley, J E Murphy-Ullrich, R M Albrecht, et al.
The Journal of Biological Chemistry
|
December 29, 1998
Functional beta1-integrins release the suppression of fibronectin matrix assembly by vitronectin
Q Zhang, T Sakai, J Nowlen, et al.
The Journal of Biological Chemistry
|
December 23, 1994
Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells
H Chen, J Sottile, K M O'Rourke, et al.
The Journal of Biological Chemistry
|
May 5, 1988
Altered metabolism of thrombospondin by Chinese hamster ovary cells defective in glycosaminoglycan synthesis
J E Murphy-Ullrich, L G Westrick, J D Esko, et al.
The Journal of Biological Chemistry
|
June 15, 1993
Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin
M C Naski, D A Lawrence, D F Mosher, et al.
Blood
|
December 1, 1989
Identification of vitronectin as a major plasma protein adsorbed on polymer surfaces of different copolymer composition
M D Bale, L A Wohlfahrt, D F Mosher, et al.
The Journal of Laboratory and Clinical Medicine
|
February 1, 1997
Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2
T S Panetti, H Chen, T M Misenheimer, et al.
Journal of Medical Primatology
|
January 1, 1977
Disseminated intravascular coagulopathy during experimental pneumococcal sepsis: studies in normal and asplenic rhesus monkeys
H B Hawley, T Yamada, D F Mosher, et al.
Cancer
|
July 15, 1990
Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide
R D McCroskey, D F Mosher, C D Spencer, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 2, 1999
Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid
J Meerschaert, E A Kelly, D F Mosher, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 219) with videos related to
Sort By:
Page
of 22
Experimental Cell Research
|
May 1, 1983
The effect of the dimeric and multimeric forms of fibronectin on the adhesion and growth of primary glomerular cells
T D Oberley, J E Murphy-Ullrich, R M Albrecht, et al.
The Journal of Biological Chemistry
|
December 29, 1998
Functional beta1-integrins release the suppression of fibronectin matrix assembly by vitronectin
Q Zhang, T Sakai, J Nowlen, et al.
The Journal of Biological Chemistry
|
December 23, 1994
Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells
H Chen, J Sottile, K M O'Rourke, et al.
The Journal of Biological Chemistry
|
May 5, 1988
Altered metabolism of thrombospondin by Chinese hamster ovary cells defective in glycosaminoglycan synthesis
J E Murphy-Ullrich, L G Westrick, J D Esko, et al.
The Journal of Biological Chemistry
|
June 15, 1993
Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin
M C Naski, D A Lawrence, D F Mosher, et al.
Blood
|
December 1, 1989
Identification of vitronectin as a major plasma protein adsorbed on polymer surfaces of different copolymer composition
M D Bale, L A Wohlfahrt, D F Mosher, et al.
The Journal of Laboratory and Clinical Medicine
|
February 1, 1997
Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2
T S Panetti, H Chen, T M Misenheimer, et al.
Journal of Medical Primatology
|
January 1, 1977
Disseminated intravascular coagulopathy during experimental pneumococcal sepsis: studies in normal and asplenic rhesus monkeys
H B Hawley, T Yamada, D F Mosher, et al.
Cancer
|
July 15, 1990
Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide
R D McCroskey, D F Mosher, C D Spencer, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 2, 1999
Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid
J Meerschaert, E A Kelly, D F Mosher, et al.
Page
of 22